Risk of HAART therapy in hepatitis C
Open Access
- 1 March 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (3), 730
- https://doi.org/10.1053/jhep.2002.32094
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disordersHepatology, 2001
- Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiologyHepatology, 2001
- Origin and Structural Evolution of the Early Proliferating Oval Cells in Rat LiverThe American Journal of Pathology, 2001
- CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitisJournal of Clinical Investigation, 2000
- Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathwayHepatology, 2000
- Does steatohepatitis impair liver regeneration? A study in a dietary model of non‐alcoholic steatohepatitis in ratsJournal of Gastroenterology and Hepatology, 1999
- Combination Therapy with Didanosine and Interferon-a in Human Immunodeficiency Virus-Infected Patients: Results of a Phase I/II TrialThe Journal of Infectious Diseases, 1996
- Prevention by Methionine of Enhancement of Hepatocarcinogenesis by Coadministration of a Choline‐deficient L‐Amino Acid‐defined Diet and Ethionine in RatsJapanese Journal of Cancer Research, 1995
- Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicityPharmacology & Therapeutics, 1995
- The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regenerationHepatology, 1988